PROSPECTIVE SINGLE COHORT STUDY OF AGN1 LOEP

 
Agnovos logo white bg
  • Principal investigator: J. Howe
  • Summary: This prospective cohort study enrolling 12 postmenopausal osteoporotic women showed that minimally invasive treatment with AGN1 LOEP (local-enhancement procedure) treatment performed on the femur significantly increased aBMD and FEA-estimated femoral strength in the treated femur for 5-7 years. In addition,  resorption of AGN1 and its replacement by bone was almost complete by 24 weeks.
  • Country: United States
  • Cohort: 12 postmenopausal osteoporotic women
  • Age: 56-89 years
  • Duration: 5-7 years follow-up
  • Endpoints: adverse events – proximal femur aMD – bone strength – AGN1 resorption and replacement with bone

Learn more

 

TITLE

 
Placeholder logo
  • Principal investigator: XXXXXXX
  • Summary: XXXXXXXXXXXXXXXXXXXX
  • Country: XXXXXXX
  • Cohort: XXXXXXXX
  • Age: XX years
  • Duration: XXXXXXX
  • Endpoints: XXXXXXXXXXX

Learn more